Cover - shares |
6 Months Ended | |
|---|---|---|
Jun. 30, 2026 |
Aug. 11, 2026 |
|
| Cover [Abstract] | ||
| Entity Registrant Name | ARTELO BIOSCIENCES, INC. | |
| Entity Central Index Key | 0001621221 | |
| Document Type | 10-Q/A | |
| Amendment Flag | true | |
| Current Fiscal Year End Date | --12-31 | |
| Entity Small Business | true | |
| Entity Shell Company | false | |
| Entity Emerging Growth Company | false | |
| Entity Current Reporting Status | Yes | |
| Document Period End Date | Jun. 30, 2026 | |
| Entity Filer Category | Non-accelerated Filer | |
| Document Fiscal Period Focus | Q2 | |
| Document Fiscal Year Focus | 2026 | |
| Entity Common Stock Shares Outstanding | 4,595,068 | |
| Entity File Number | 001-38951 | |
| Entity Incorporation State Country Code | NV | |
| Entity Tax Identification Number | 33-1220924 | |
| Entity Address Address Line 1 | 505 Lomas Santa Fe | |
| Entity Address Address Line 2 | Suite 160 | |
| Entity Address City Or Town | Solana Beach | |
| Entity Address State Or Province | CA | |
| Entity Address Postal Zip Code | 92075 | |
| City Area Code | 858 | |
| Local Phone Number | 925-7049 | |
| Security 12b Title | Common Stock, $0.001 par value per share | |
| Trading Symbol | ARTL | |
| Security Exchange Name | NASDAQ | |
| Entity Address Country | US | |
| Document Quarterly Report | true | |
| Document Transition Report | false | |
| Entity Interactive Data Current | Yes | |
| Amendment Description | The purpose of this Amendment No. 1 (this “Amendment”) to the Quarterly Report on Form 10-Q of Artelo Biosciences, Inc. (the “Company”) for the period ended June 30, 2026 (the “Original Report”), as filed with the Securities and Exchange Commission (the “SEC”) on August 12, 2026, is solely to amend Part II “Item 1. Legal Proceedings” to include information regarding an arbitration claim that was inadvertently omitted from the Original Report. In addition, as required by Rule 12b-15 under the Securities Exchange Act of 1934, as amended, new certifications of our principal executive officer and principal financial officer are filed as exhibits to this Amendment under Part II “Item 6. Exhibits”. Except as described above, this Amendment makes no other changes to the Original Report. This Amendment does not reflect subsequent events occurring after the original filing of the Original Report or modify or update in any way those disclosures that may be affected by subsequent events. Accordingly, this Amendment should be read in conjunction with the Original Report and our other filings with the SEC. |